Cite
HARVARD Citation
Buil, J. et al. (2018). Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs. Journal of antimicrobial chemotherapy. pp. 134-142. [Online].